VBI Vaccines Inc expected to post a loss of 7 cents a share - Earnings Preview

VBI Vaccines

03/11/2021 09:42

* VBI Vaccines Inc  VBIV.OQ   VBIV.O  is expected to show a fall
in quarterly revenue when it reports  results on November 3
(estimated). 
* The Cambridge, Massachusetts-based company is expected to
report  a 31.7% decrease in revenue to $203.67 thousand from
$298 thousand a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for VBI Vaccines Inc is for
a loss of 7 cents per share. For the same quarter last year, the
company reported a loss of 6 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for VBI Vaccines
Inc is $8​, about 62% above​ its last closing price
of $3.04. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 302021   -0.06       -0.06      -0.07     Missed  -23.5
 Mar. 312021   -0.06       -0.06      -0.07     Missed  -16.7
 Dec. 312020   -0.06       -0.06      -0.06     Met     -3.4​
 Sep. 302020   -0.04       -0.04      -0.06     Missed  -33.3
 ​​Jun.        -0.04       -0.04      -0.04     Met     0
 302020                                                 
 Mar. 312020   -0.06       -0.06      -0.05     Beat    20​
 Dec. 312019   -0.05       -0.06      -0.02     Beat    65.2
 Sep. 302019   -0.13       -0.13      -0.15     Missed  -18.4
 This summary was machine generated November 3 at 09:42 GMT.  All
figures in US dollars unless otherwise stated